Cardiol Therapeutics Inc (CRDL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 48 | 201 | 62 | 62 | 67 |
| Accounts receivable | -95 | -24 | 75 | -37 | 10 |
| Other Working Capital | 990 | -2,673 | 782 | -31 | 1,538 |
| Other Operating Activity | -6,537 | -5,273 | -5,694 | -6,916 | -8,080 |
| Operating Cash Flow | $-5,593 | $-7,769 | $-4,776 | $-6,923 | $-6,465 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6 | -8 | -4 | -3 | -11 |
| Investing Cash Flow | $-6 | $-8 | $-4 | $-3 | $-11 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -14 | -5 | -9 | -14 | -14 |
| Other Financing Activity | 18,704 | 0 | 87 | 90 | 0 |
| Financing Cash Flow | $18,691 | $-5 | $78 | $76 | $-14 |
| Exchange Rate Effect | 1,604 | -355 | 150 | 491 | 881 |
| Beginning Cash Position | 15,885 | 24,021 | 28,573 | 34,932 | 40,540 |
| End Cash Position | 30,580 | 15,885 | 24,021 | 28,573 | 34,932 |
| Net Cash Flow | $13,091 | $-7,782 | $-4,701 | $-6,850 | $-6,489 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,593 | -7,769 | -4,776 | -6,923 | -6,465 |
| Capital Expenditure | -6 | -8 | -4 | -3 | -11 |
| Free Cash Flow | -5,599 | -7,777 | -4,780 | -6,926 | -6,475 |